Literature DB >> 21416177

Linking epidermal growth factor plasma levels with the prognosis and treatment response of colorectal cancer patients treated with a minimally invasive approach: does it have clinical utility?

John Spiliotis, Odysseas Zoras.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21416177     DOI: 10.1007/s00464-011-1622-4

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


× No keyword cloud information.
  25 in total

1.  Complete genome sequencing and network modeling to overcome trastuzumab resistance.

Authors:  Dimitrios H Roukos
Journal:  Pharmacogenomics       Date:  2010-08       Impact factor: 2.533

2.  Laparoscopic surgery for gastric cancer: comparative-effectiveness research and future trends.

Authors:  Christos G Katsios; George Baltogiannis; Dimitrios H Roukos
Journal:  Expert Rev Anticancer Ther       Date:  2010-04       Impact factor: 4.512

Review 3.  Systems medicine: a real approach for future personalized oncology?

Authors:  Dimitrios H Roukos
Journal:  Pharmacogenomics       Date:  2010-03       Impact factor: 2.533

Review 4.  Trastuzumab and beyond: sequencing cancer genomes and predicting molecular networks.

Authors:  D H Roukos
Journal:  Pharmacogenomics J       Date:  2010-10-26       Impact factor: 3.550

5.  Randomized evidence for laparoscopic gastrectomy short-term quality of life improvement and challenges for improving long-term outcomes.

Authors:  Theodore Liakakos; Dimitrios H Roukos
Journal:  Ann Surg       Date:  2009-08       Impact factor: 12.969

6.  Is there any long-term benefit in quality of life after laparoscopy-assisted distal gastrectomy for gastric cancer?

Authors:  Theodore Liakakos; Dimitrios H Roukos
Journal:  Surg Endosc       Date:  2008-03-26       Impact factor: 4.584

7.  Current concerns and challenges regarding tailored anti-angiogenic therapy in cancer.

Authors:  Dimitrios H Roukos; Andreas Tzakos; George Zografos
Journal:  Expert Rev Anticancer Ther       Date:  2009-10       Impact factor: 4.512

8.  From tumor size and HER2 status to systems oncology for very early breast cancer treatment.

Authors:  Dimitrios H Roukos; Dimosthenis Ziogas
Journal:  Expert Rev Anticancer Ther       Date:  2010-02       Impact factor: 4.512

9.  Cancer genome explosion and systems biology: impact on surgical oncology?

Authors:  Dimitrios H Roukos
Journal:  Ann Surg Oncol       Date:  2011-01       Impact factor: 5.344

10.  Targeting gastric cancer with trastuzumab: new clinical practice and innovative developments to overcome resistance.

Authors:  Dimitrios H Roukos
Journal:  Ann Surg Oncol       Date:  2009-10-20       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.